Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $24.30 --0%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Join SI Premium – FREE
Barclays analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $48.00 (from $56.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Downgrades China Resources Cement Holdings (1313:HK) (CARCY) to Sell
- Baoshan Iron & Steel Co Ltd (600019:CH) PT Lowered to RMB6.10 at Goldman Sachs
- China Coal Energy Co Ltd. (601898:CH) PT Lowered to RMB22 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
